These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 2861935)
21. [Duration of the therapeutic effect of a beta 2 stimulant (procaterol hydrochloride) in patients with asthmatiform bronchopathies]. Cammarata A; Mazzarella G; Grella E; Liccardo G Arch Monaldi Mal Torace; 1988; 43(2):131-40. PubMed ID: 2908377 [No Abstract] [Full Text] [Related]
22. Comparison of cardiorespiratory effects of procaterol and salbutamol in asthmatic patients. Youngchaiyud P J Med Assoc Thai; 1982 Feb; 65(2):86-94. PubMed ID: 6122706 [No Abstract] [Full Text] [Related]
23. Dissociation of tracheobronchial and cardiac effects of some beta-adrenergic stimulants. Hinds L; Katz RL Anesthesiology; 1971 May; 34(5):445-9. PubMed ID: 4396619 [No Abstract] [Full Text] [Related]
24. Studies on the effects of enantiomers of soterenol, trimetoquinol and salbutamol on beta adrenergic receptors of isolated guinea-pig atria and trachea. Buckner CK; Abel P J Pharmacol Exp Ther; 1974 Jun; 189(3):616-25. PubMed ID: 4152313 [No Abstract] [Full Text] [Related]
25. Recent beta-adrenoreceptor stimulants. Brittain RT; Jack D; Ritchie AC Adv Drug Res; 1970; 5():197-253. PubMed ID: 4395724 [No Abstract] [Full Text] [Related]
26. [3'-Cyanophenylalcanolamine: a contribution to the study of selective beta-adrenomimetic compounds]. Pratesi P; Grana E; Villa L Farmaco Sci; 1973 Oct; 28(10):753-65. PubMed ID: 4147785 [No Abstract] [Full Text] [Related]
27. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists. Lish PM; Weikel JH; Dungan KW J Pharmacol Exp Ther; 1965 Aug; 149(2):161-73. PubMed ID: 4378558 [No Abstract] [Full Text] [Related]
28. Phenoxypropanolamines as selective beta 1-receptor agonists. Raper C; McPherson GA; Malta E Circ Res; 1980 Jun; 46(6 Pt 2):I53-4. PubMed ID: 6103761 [TBL] [Abstract][Full Text] [Related]
29. Relationship between intrinsic activities of agonists in normal and desensitized tissue and agonist-induced loss of beta adrenergic receptors. Pittman RN; Reynolds EE; Molinoff PB J Pharmacol Exp Ther; 1984 Sep; 230(3):614-8. PubMed ID: 6147404 [TBL] [Abstract][Full Text] [Related]
30. Studies on tetrahydroisoquinolines (THI). VI. Effects of trimetoquinol on tracheal and some other smooth muscles. Kiyomoto A; Iwasawa Y; Harigaya S Arzneimittelforschung; 1970 Jan; 20(1):46-52. PubMed ID: 4392500 [No Abstract] [Full Text] [Related]
31. [Preclinical study of third generation beta 2-stimulant (procaterol) on inhibition of uterine contraction (author's transl)]. Chimura T Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jul; 34(7):899-904. PubMed ID: 6125547 [TBL] [Abstract][Full Text] [Related]
32. Beta-adrenoceptor desensitization in a model of experimental asthma in guinea-pigs. Daffonchio L; Abbracchio MP; Di Luca M; Pasargiklian R; Galli P; Hernandez A; Omini C Eur Respir J Suppl; 1989 Jun; 6():512s-515s. PubMed ID: 2572227 [TBL] [Abstract][Full Text] [Related]
33. [Procaterol in the prevention of recurrent asthmatic bronchitis. Double-blind study]. Corrias A; Corona GB; Pelosi U; Cozzolino L; Corda R Pediatr Med Chir; 1988; 10(2):165-7. PubMed ID: 2902601 [TBL] [Abstract][Full Text] [Related]
34. [Pharmacodynamic study of a new antiasthmatic drug. Salbutamol]. Foussard-Blanpin O; Narcisse G Therapie; 1971; 26(6):1081-96. PubMed ID: 4401716 [No Abstract] [Full Text] [Related]
35. [Effect of stimulation of adrenergic bronchial beta receptors by terbutalin on the bronchomotoric effects of propranolol and acetylcholine]. Růzicka J; Vondra V; Spicák V Cas Lek Cesk; 1973 Aug; 112(34):1038-41. PubMed ID: 4147309 [No Abstract] [Full Text] [Related]
36. Structure-activity relationships in further series of amino-halogen substituted phenyl-aminoethanols. Engelhardt G Arzneimittelforschung; 1984; 34(11A):1625-32. PubMed ID: 6152155 [TBL] [Abstract][Full Text] [Related]
37. Activation of beta 2-adrenergic receptors and ventricular fibrillation. Billman GE; Altschuld RA Cardiologia; 1998 Aug; 43(8):811-8. PubMed ID: 9808871 [No Abstract] [Full Text] [Related]
38. In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure. Kenakin TP; Beek D J Pharmacol Exp Ther; 1982 Jan; 220(1):77-85. PubMed ID: 6118432 [No Abstract] [Full Text] [Related]
39. Synthesis of procaterol derivative having a piperidylmethanol group and its beta-adrenoceptor stimulant activities. Yoshizaki S; Tamada S; Umezato M; Yabuuchi Y Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3403-4. PubMed ID: 2576644 [TBL] [Abstract][Full Text] [Related]
40. ICI 147,798: a novel diuretic agent with beta adrenoceptor blocking activity. Kau ST; Howe BB; Li JH; Smith LH; Keddie JR; Barlow JJ; Giles RE; Goldberg ME J Pharmacol Exp Ther; 1987 Sep; 242(3):818-26. PubMed ID: 2888873 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]